Literature DB >> 1928204

Use of N-acetylcysteine in clinical toxicology.

R J Flanagan1, T J Meredith.   

Abstract

The major use of N-acetylcysteine in clinical toxicology is in the treatment of acetaminophen (paracetamol) overdosage. The hepatorenal toxicity of acetaminophen is mediated by a reactive metabolite normally detoxified by reduced glutathione. If glutathione is depleted, covalent binding to macromolecules and/or oxidation of thiol enzymes can lead to cell death. Oral or intravenous N-acetylcysteine or oral D,L-methionine mitigates acetaminophen-induced hepatorenal damage if given within 10 hours, but becomes less effective thereafter. In vivo, N-acetylcysteine forms L-cysteine, cystine, L-methionine, glutathione, and mixed disulfides; L-methionine also forms cysteine, thus giving rise to glutathione and other products. Oral therapy with N-acetylcysteine or methionine for acetaminophen poisoning is contraindicated in the presence of coma or vomiting, or if activated charcoal has been given by mouth. Nausea, vomiting, and diarrhea may also occur as a result of oral N-acetylcysteine administration. Anaphylactoid reactions including angioedema, bronchospasm, flushing, hypotension, nausea/vomiting, rash, tachycardia, and respiratory distress may occur 15-60 minutes into N-acetylcysteine infusion (20 hours intravenous regimen) in up to 10% of patients. Following accidental intravenous overdosage, the adverse reactions of N-acetylcysteine are similar but more severe; fatalities have occurred. A reduction in the loading dose of N-acetylcysteine may reduce the risk of adverse reactions while maintaining efficacy. Administration of N-acetylcysteine for a longer period might provide enhanced protection for patients in whom acetaminophen absorption or elimination is delayed. N-acetylcysteine may also have a role in the treatment of toxicity from carbon tetrachloride, chloroform, 1,2-dichloropropane, and other compounds. The possible use of N-acetylcysteine and other agents in the prevention of the neuropsychiatric sequelae of acute carbon monoxide poisoning is an important area for future research.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1928204     DOI: 10.1016/0002-9343(91)90296-a

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  30 in total

1.  N-acetylcysteine protects striated muscle in a model of compartment syndrome.

Authors:  Stephen R Kearns; David E O'Briain; Katherine M Sheehan; Cathal Kelly; David Bouchier-Hayes
Journal:  Clin Orthop Relat Res       Date:  2010-03-23       Impact factor: 4.176

2.  New recommendation for N-acetylcystiene dosing may reduce incidence of adverse effects.

Authors:  R Duncan; G Cantlay; B Paterson
Journal:  Emerg Med J       Date:  2006-07       Impact factor: 2.740

3.  Deaths from low dose paracetamol poisoning. Executive action is needed to change national guidelines.

Authors:  J Barnes; M Abban; P Howarth
Journal:  BMJ       Date:  1998-12-12

Review 4.  Clinical applications of commonly used contemporary antidotes. A US perspective.

Authors:  C A Bowden; E P Krenzelok
Journal:  Drug Saf       Date:  1997-01       Impact factor: 5.606

5.  Applications of Synthetic Organic Tetrasulfides as H2S Donors.

Authors:  Matthew M Cerda; Matthew D Hammers; Mary S Earp; Lev N Zakharov; Michael D Pluth
Journal:  Org Lett       Date:  2017-04-25       Impact factor: 6.005

6.  N-acetylcysteine reduces extinction responding and induces enduring reductions in cue- and heroin-induced drug-seeking.

Authors:  Wenhua Zhou; Peter W Kalivas
Journal:  Biol Psychiatry       Date:  2007-08-24       Impact factor: 13.382

7.  A biodistribution and toxicity study of cobalt dichloride-N-acetyl cysteine in an implantable MRI marker for prostate cancer treatment.

Authors:  Steven J Frank; Mary J Johansen; Karen S Martirosyan; Mihai Gagea; Carolyn S Van Pelt; Agatha Borne; Yudith Carmazzi; Timothy Madden
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-10-22       Impact factor: 7.038

8.  N-acetyl cysteine therapy in acute viral hepatitis.

Authors:  Huseyin Gunduz; Oguz Karabay; Ali Tamer; Resat Ozaras; Ali Mert; Omer Fehmi Tabak
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

9.  Inhibition of mitochondrial respiration in vivo is an early event in acetaminophen-induced hepatotoxicity.

Authors:  P J Donnelly; R M Walker; W J Racz
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

10.  Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning.

Authors:  L E Schmidt; K Dalhoff
Journal:  Br J Clin Pharmacol       Date:  2001-01       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.